← Back to All Filings

Natera Exec Sells $596K in Stock Under Pre-Arranged 10b5-1 Plan

Low SignificanceNovember 4, 2025 at 10:01:59 PM EST

Natera, Inc.

$NTRA4CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Natera Exec Sells $596K in Stock Under Pre-Arranged 10b5-1 Plan

Company: Natera, Inc. (NTRA) Form: 4 | Filed: 2025-11-04 Significance: Low

Insider: Moshkevich Solomon Title: PRESIDENT, CLINICALDIAGNOSTICS | Relationship: Officer

Transaction: • Type: Sell • Shares: 3,000 • Price: ~$198.60 (avg) • Value: $595,810 • Owned After: 112,061

Key Insight: A President at Natera sold a small portion (~2.6%) of their holdings under a pre-scheduled 10b5-1 trading plan, indicating the sale was likely for personal financial management rather than a reflection of company outlook.

Market Context: The transaction is minor, representing just 0.002% of Natera's $27.21B market cap. Such planned sales by executives are routine and typically have no market impact.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Natera, Inc. (NTRA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A company President conducted a small, pre-planned sale of common stock, representing a negligible fraction of the company's market capitalization and the insider's total holdings.
  • Market Impact: Neutral. The transaction was executed under a Rule 10b5-1 plan, which strips it of most informational value regarding the company's future prospects.

Company Information

FieldValue
CompanyNatera, Inc.
Ticker SymbolNTRA
CIK0001604821
IndustrySERVICES-MEDICAL LABORATORIES

Insider Information

FieldValue
NameMoshkevich Solomon
CIK0002010019
Title/PositionPRESIDENT, CLINICALDIAGNOSTICS
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-03
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved3,000
Average Price Per Share$198.60
Total Value$595,810
Shares Owned After112,061
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$595,810.04
% of Market Cap0.002%
Shares Transacted3,000
% of Shares Outstanding0.002%
Post-Transaction Ownership112,061 shares (0.082% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The ~$596k sale is insignificant relative to Natera's $27.21 billion market capitalization.
  • Ownership Concentration: The insider's post-transaction ownership of 0.082% is not a controlling stake. The sale of 3,000 shares represents only about 2.6% of the insider's prior holdings, indicating it was not a major liquidation event.
  • Transaction Significance: The transaction is considered routine and not significant due to its small size relative to both market cap and shares outstanding.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The sale was conducted under a pre-arranged 10b5-1 plan, indicating it was for personal liquidity or diversification, not a reaction to non-public information. The size is too small to influence the market.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is a tiny fraction of typical daily trading volume for a multi-billion dollar company.
  • Sentiment Indicator: Neutral. Pre-planned sales are common and do not typically affect market sentiment.

Additional Context

Special Circumstances

  • The filing explicitly states the sale was made pursuant to a Rule 10b5-1 trading plan adopted by the insider on November 26, 2024. This automates transactions and is a defense against accusations of trading on inside information.
Topics:#SECFiling#InsiderTrading#NTRA#Natera#Form4#InsiderSell#StockMarket#10b51

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.